MedPath

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Phase 3
Completed
Conditions
HIV Infections
Registration Number
NCT00002409
Lead Sponsor
Glaxo Wellcome
Brief Summary

The purpose of this study is to see if an HIV-education course can help under-represented, HIV-infected patients. This study examines the areas of faithfulness to drug regimen, level of HIV in the blood, and health status.

Detailed Description

Following initial screening, eligible patients are treated with open-label Combivir plus abacavir for 24 weeks. Patients are randomized to undergo the education intervention, Tools for Health and Empowerment (T.H.E.) course plus counseling, or routine counseling only (control group). Measurements and evaluations for assessment of immunologic effects, adherence, and health outcomes are performed at entry (Day 1) and at Weeks 2, 5, 8, 12, 16, and 24.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (25)

AIDS Healthcare Foundation

🇺🇸

Los Angeles, California, United States

Oasis Clinic / King Drew Med Ctr

🇺🇸

Los Angeles, California, United States

Robert Scott MD

🇺🇸

Oakland, California, United States

Georgetown Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

Whitman Walker Clinic/Elizabeth Taylor Med Ctr

🇺🇸

Washington, District of Columbia, United States

Univ of Miami School of Medicine

🇺🇸

Miami, Florida, United States

Specialty Med Care Ctrs of South Florida Inc

🇺🇸

Miami, Florida, United States

Saint Josephs Comprehensive Research Institute

🇺🇸

Tampa, Florida, United States

AIDS Research Consortium of Atlanta

🇺🇸

Atlanta, Georgia, United States

Rush Med College / Dept of Infectious Diseases

🇺🇸

Chicago, Illinois, United States

Scroll for more (15 remaining)
AIDS Healthcare Foundation
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.